This study aimed at investigating whether PCT could be adopted as a biological marker for diagnosing bacterial infection and guiding antibiotic therapy in patients with fever after TACE and/or RFA to treat HCC. This evidence concerns the gene CALCA and hepatocellular carcinoma.